A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin

J. B. Vermorken, A. Kobierska, B. Chevallier, F. Zanaboni, A. Pawinski, G. Bolis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences